AKT1 and ovarian carcinoma: Studies show that the PI3K/Akt signaling pathway is abnormally activated in ovarian cancer tissues compared to normal tissues, with higher PI3K mutations and increased Akt expression, and the PI3K/Akt signaling pathway is considered to be one of the major pathways involved in ovarian progression [47,48].